13 recruiting. 13 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 13 | Recruiting 13 |
| Phase 2 | 3 | Recruiting 3 |
Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With Asthma CHF10136, CHF10136 matched placebo - Asthma, Healthy Volunteers | Phase 1 | Recruiting | Chiesi Farmaceutici S.p.A. | 120 | 2026-10-02 | 2026-10-13 |
| A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma SKB575, Placebo - Asthma (Diagnosis) | Phase 1 | Recruiting | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 36 | 2026-08-25 | 2026-09-10 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma PF-08103402, Placebo, Midazolam - Healthy Volunteer Study, Healthy Adults | Phase 1 | Recruiting | Pfizer | 133 | 2026-06-17 | 2026-11-03 |
| A Study of CDX-622 in Participants With Mild to Moderate Asthma CDX-622 - Mild to Moderate Asthma | Phase 1 | Recruiting | Celldex Therapeutics | 12 | 2026-06-01 | 2026-07-02 |
| Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma PRA-216, Placebo - Mild to Moderate Asthma | Phase 1 / Phase 2 | Recruiting | Prana Therapies Inc | 96 | 2025-11-04 | 2026-08-06 |
| A Study of HB0056 in Adult Participants With Moderate to Severe Asthma Placebo, HB0056 - Asthma | Phase 1 / Phase 2 | Recruiting | Shanghai Huaota Biopharmaceutical Co., Ltd. | 160 | 2025-08-21 | 2026-10-28 |
| Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma ALUTARD SQ® Felis domesticus - Allergic Rhinitis, Allergic Asthma | Phase 1 / Phase 2 | Recruiting | University of Zurich | 36 | 2025-08-20 | 2026-03-16 |
| The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges Adenosine 5'-triphosphate - Chronic Cough (CC), Asthma | Phase 1 | Recruiting | McMaster University | 33 | 2025-08-05 | 2025-08-29 |
| A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma Placebo, IBI3002 - Asthma | Phase 1 | Recruiting | The First Affiliated Hospital of Soochow University | 12 | 2025-06-20 | 2025-11-19 |
| A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive Salbutamol HFA-152a, Salbutamol HFA-134a, Placebo - Asthma, Mild Asthma | Phase 1 | Recruiting | GlaxoSmithKline | 84 | 2024-08-14 | 2026-11-06 |
| Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Pulmonary Diseases cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells - Pulmonary Disease, Asthma | Phase 1 | Recruiting | The Foundation for Orthopaedics and Regenerative Medicine | 20 | 2021-12-01 | 2026-10-16 |
| Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease Hyperpolarized Xe129 - Asthma, COPD | Phase 1 | Recruiting | Mario Castro, MD, MPH | 260 | 2020-11-02 | 2026-05-06 |
| Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage - Asthma | Phase 1 | Recruiting | Benjamin Medoff | 313 | 2008-01-01 | 2026-11-06 |
Pulmonary Disease, Chronic Obstructive (2) · Chronic Cough (1) · Cystic Fibrosis (1) · Disease (1) · Hypertension, Pulmonary (1) · Inflammation (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Rhinitis (1) · Rhinitis, Allergic (1) · cough hypersensitivity syndrome (1)
Bronchial Diseases (13) · Hypersensitivity (13) · Hypersensitivity, Immediate (13) · Immune System Diseases (13) · Lung Diseases, Obstructive (13) · Respiratory Hypersensitivity (13) · Respiratory Tract Diseases (13) · Lung Diseases (12) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Chronic Disease (2) · Disease Attributes (2) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cough (1)
Adenosine Triphosphate (1) · Bronchoscopy (1) · Midazolam (1)
Benjamin Medoff (1) · Celldex Therapeutics (1) · Chiesi Farmaceutici S.p.A. (1) · GlaxoSmithKline (1) · Mario Castro, MD, MPH (1) · McMaster University (1) · Pfizer (1) · Prana Therapies Inc (1) · Shanghai Huaota Biopharmaceutical Co., Ltd. (1) · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (1) · The First Affiliated Hospital of Soochow University (1) · The Foundation for Orthopaedics and Regenerative Medicine (1) · University of Zurich (1)
United States (5) · China (3) · United Kingdom (2) · Australia (1) · Belgium (1) · Canada (1) · Greece (1) · New Zealand (1) · Switzerland (1)
Benjamin D Medoff, MD, PhD (1) · Peter Niedbalski, PHD (1) · Rory Taylor, MD (1)